Status:
ENROLLING_BY_INVITATION
Primary HPV Self-Collection in Indonesia
Lead Sponsor:
Dharmais National Cancer Center Hospital
Collaborating Sponsors:
M.D. Anderson Cancer Center
Conditions:
Cervical Cancers
CIN - Cervical Intraepithelial Neoplasia
Eligibility:
FEMALE
30-69 years
Phase:
NA
Brief Summary
The purpose of this study is to implement human papillomavirus (HPV) self-collection in Indonesia.
Detailed Description
After participants give informed consent, they will receive a short educational session about cervical cancer and HPV, after which they will be offered the opportunity to undergo primary HR-HPV testin...
Eligibility Criteria
Inclusion
- Age 30-69 years old
- Have not had a Pap test within the last 3 years or an HPV test within the last 5 years
- Have never been diagnosed with cervical cancer or high-grade dysplasia
- Have no history of hysterectomy with cervical removal
- Expressed willingness to participate in the study, including conducting HPV self-collection, follow-up treatment, and related surveys
Exclusion
- Being pregnant or within 6 weeks postpartum
- Women who have never engaged in sexual activity
- Medical, psychiatric, or other conditions that may interfere with compliance with protocols, security assessments, and/or ability/competence to give informed consent
- Adults who do not have the capacity to give consent may be excluded, as participants must be able to perform activities required by the protocol
Key Trial Info
Start Date :
August 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT06942286
Start Date
August 13 2025
End Date
April 1 2027
Last Update
September 17 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Puskesmas Lebak
Lebak, Banten, Indonesia
2
Dharmais National Cancer Center Hospital
Jakarta, Jakarta Special Capital Region, Indonesia, 11420
3
Puskesmas Depok
Depok, West Java, Indonesia